Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 11, 2011, Pages 1613-1618

  Lu, Jian Guang ^a   Li, Yong ^a   Li, Liang ^a   Kan, Xuan ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Differentiation; Hypopharyngeal neoplasms; Integrin v; Laryngeal neoplasms; Metastasis; Osteopontin

Indexed keywords

CD51 ANTIGEN; OSTEOPONTIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL FUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAV; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OSTEOPONTIN;

EID: 80054752536     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1024-y     Document Type: Article

References (25)

1. D Agrawal T Chen R Irby J Quackenbush AF Chambers M Szabo D Coppola TJ Yeatman 2002 Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 513 521 11929952 1:CAS:528:DC%2BD38Xjt1Ciurw%3D (Pubitemid 34411290)
2. A Celetti D Testa S Staibano F Merolla V Guarino MD Castellone R Iovine G Mansueto P Somma G De Rosa V Galli RM Melillo M Santoro 2005 Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and evasiveness Clin Cancer Res 11 22 8019 8027 16299231 10.1158/1078-0432.CCR-05-0641 1:CAS:528: DC%2BD2MXht1entr7E (Pubitemid 41698743)
3. AF Chambers SM Wilson N Kerkvliet FP O'Malley JF Harris AG Casson 1996 Osteopontin expression in lung cancers Lung Cancer 15 311 323 8959677 10.1016/0169-5002(95)00595-1 1:STN:280:DyaK2s7hvVygtw%3D%3D (Pubitemid 26399511)
4. D Coppola M Szabo D Boulware 2004 Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin Cancer Res 10 184 190 14734468 10.1158/1078-0432.CCR-1405-2 1:CAS:528:DC%2BD2cXkvF2msg%3D%3D (Pubitemid 38114178)
5. DT Denhardt CM Giachelli SR Rittling 2001 Role of osteopontin in cellular signaling and toxicant injury Annu Rev Pharmacol Toxicol 41 723 749 11264474 10.1146/annurev.pharmtox.41.1.723 1:CAS:528:DC%2BD3MXjsVaqt7Y%3D (Pubitemid 32385904)
6. KA Furger RK Menon AB Tuck VH Bramwell AF Chambers 2001 The functional and clinical roles of osteopontin in cancer and metastasis Curr Mol Med 1 621 632 11899236 10.2174/1566524013363339 1:CAS:528:DC%2BD3MXotlCrtbg%3D (Pubitemid 33772040)
7. KA Hruska F Rolnick M Huskey U Alvarez D Cheresh 1995 Engagement of the osteoclast integrin αvβ3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity Endocrinology 136 2984 2992 7540546 10.1210/en.136.7.2984 1:CAS:528:DyaK2MXmsFWnsL8%3D
8. DD Hu EC Lin NL Kovach JR Hoyer JW Smith 1995 A biochemical characterization of the binding of osteopontin to integrins αvβ1 and αvβ5 J Biol Chem 270 26232 26238 7592829 10.1074/jbc.270.44.26232 1:CAS:528:DyaK2MXpt1eju7g%3D
9. YU Katagiri J Sleeman H Fujii P Herrlich H Hotta K Tanaka S Chikuma H Yagita K Okumura M Murakami I Saiki AF Chambers T Uede 1999 CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis Cancer Res 59 219 226 9892210 1:CAS:528: DyaK1MXms1eguw%3D%3D (Pubitemid 29062981)
10. S Kon Y Yokosaki M Maeda T Segawa Y Horikoshi H Tsukagoshi MM Rashid J Morimoto M Inobe N Shijubo AF Chambers T Uede 2002 Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences J Cell Biochem 84 420 432 11787071 10.1002/jcb.10039 (Pubitemid 34033300)
11. CC Kumar 1998 Signaling by integrin receptors Oncogene 17 1365 1373 9779984 10.1038/sj.onc.1202172 1:CAS:528:DyaK1cXmsVyntLc%3D
12. L Licitra J Bernier C Grandi 2003 Cancer of the larynx Crit Rev Oncol Hematol l47 65 80 10.1016/S1040-8428(03)00017-9 (Pubitemid 36802324)
13. E Medico A Gentile CC Lo TA Williams G Gambarotta L Trusolino PM Comoglio 2001 Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth Cancer Res 61 5861 5868 11479227 1:CAS:528:DC%2BD3MXlvVCgurk%3D (Pubitemid 32769106)
14. AJ Oates R Barraclough PS Rudland 1997 The role of osteopontin in tumorigenesis and metastasis Invasion Metastasis 17 1 15 9425320 1:CAS:528:DyaK1cXjsFehsw%3D%3D (Pubitemid 27525063)
15. Rosai J, Carcangiu ML, DeLellis RA (1992) Atlas of tumor pathology-tumors of the larynx, 3rd series. Armed Force Institute of Pathology, Washington
16. E Ruoslahti 1991 Integrins J Clin Invest 87 1 5 1985087 10.1172/JCI114957 1:CAS:528:DyaK3MXnslSqsg%3D%3D
17. DR Senger SR Ledbetter KP Claffey A Papadopoulos-Sergiou CA Perruzzi M Detmar 1996 Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the 3 integrin, osteopontin, and thrombin Am J Pathol 149 293 305 8686754 1:CAS:528:DyaK28XkslKhtr8%3D (Pubitemid 26231000)
18. GN Thalmann RA Sikes RE Devoll JA Kiefer R Markwalder I Klima 1999 Osteopontin: possible role in prostate cancer progression Clin Cancer Res 5 2271 2277 10473115 1:CAS:528:DyaK1MXlvVOgsrs%3D (Pubitemid 29399287)
19. AB Tuck AF Chambers 2001 The role of osteopontin in breast cancer: clinical and experimental studies J Mamm Gland Biol Neoplasia 6 419 429 10.1023/A:1014734930781 1:STN:280:DC%2BD383ntVGlsg%3D%3D (Pubitemid 39600499)
20. AB Tuck FP Malley H Singhal KS Tonkin JF Harris D Bautista 1997 Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas Arch Pathol Lab Med 121 578 584 9199622 1:STN:280:DyaK2szkt12ktw%3D%3D (Pubitemid 27259939)
21. AB Tuck BE Elliott C Hota E Tremblay AF Chambers 2000 Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met) J Cell Biochem 78 465 475 10861844 10.1002/1097-4644(20000901)78:3<465::AID- JCB11>3.0.CO;2-C 1:CAS:528:DC%2BD3cXltlShtLs%3D (Pubitemid 30491074)
22. JA Varner DA Cheresh 1996 Integrins and cancer Curr Opin Cell Biol 8 5 724 730 8939661 10.1016/S0955-0674(96)80115-3 1:CAS:528:DyaK28Xmt12nsbk%3D (Pubitemid 26381731)
23. GF Weber 2001 The metastasis gene osteopontin: a candidate target for cancer therapy Biochim Biophys Acta 1552 61 85 11825687 1:CAS:528: DC%2BD38XhsFahs74%3D (Pubitemid 34124131)
24. NC Wong BM Mueller CF Barbas P Ruminski V Quaranta EC Lin JW Smith 1998 αv integrins mediate adhesion and migration of breast carcinoma cell lines Clin Exp Metastasis 16 50 61 9502077 10.1023/A:1006512018609 1:CAS:528:DyaK1cXhvVyitL0%3D (Pubitemid 28122555)
25. Y Yokosaki N Matsuura T Sasaki I Murakami H Schneider S Higashiyama Y Saitoh M Yamakido Y Taooka D Sheppard 1999 The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin J Biol Chem 274 36328 36334 10593924 10.1074/jbc.274.51.36328 1:CAS:528:DC%2BD3cXitF2g (Pubitemid 30005235)